Nivolumab+Ipilimumab+RT in MSS mCRC
Clinical trial NCT04575922 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04575922
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2023-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.